EnZeta Immunotherapies, Inc. — Form D/A
EnZeta Immunotherapies, Inc. of CORAL GABLES, FL, a company, filed a Form D amendment with the SEC on 2026-03-06. The offering totals $2.4M, of which $840K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-03-06
- Form: D/A
- Accession: 0001994145-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.4M
- Amount sold: $840K
- Remaining: $1.5M
- Investors: 10
- Date of first sale: 2025-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538757
Issuer
- Name: EnZeta Immunotherapies, Inc.
- CIK: 0001994145
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 122 SEVILLA AVE # 919, CORAL GABLES, FL, 33134
- Phone: 9173644613
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Paul Kelly | Related Person | Boston, MA |
| Sergio Traversa | Related Person | Blue Bell, PA |
| Paul Kelly | Director | Boston, MA |
| Paul Kelly | Executive Officer | Boston, MA |
| Sergio Traversa | Director | Blue Bell, PA |
| Traversa Sergio | Director | Coral Gables, FL |
Other filings by this issuer (3)
More